Unjha Formulations Ltd share price logo

Unjha Formulations Ltd

BSE: 531762

Small Cap

Pharma Sector

₹19.50

+0.95

(+5.12%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Unjha Formulations Stock Performance

as on July 6, 2026 at 9:31 pm IST

  • Day's High

    ₹19.50
    ₹19.99

    2.51%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹17.52
    ₹30.40
    downward going graph

    10.15%

    Downside

    55.90%

    Upside

    downward going graph

Unjha Formulations share price movements today

Previous Close
₹18.55
Open
₹19.99
Volume
1,520.00
Upper Circuit
₹22.26
Lower Circuit
₹14.84
Day's Low - High
₹19.50 - ₹19.99
52 Week Low - High
₹17.52 - ₹30.40

Unjha Formulations Historical Returns

1 Month Return
-2.5 %
3 Month Return
-0.31 %
1 Year Return
-15.18 %
3 Year Return
+ 62.5 %
5 Year Return
+ 71.05 %

Unjha Formulations Fundamentals

as on July 6, 2026 at 4:01 pm IST

Market Cap

₹8.74 Cr

Return on Equity (ROE)

8.77

PE Ratio (TTM)

0

Return on capital employed (ROCE)

11.55

Beta (LTM)

0.49

P/B Ratio

3.11

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

80.49

EPS (TTM)

0

Book Value

0

Unjha Formulations Technical Analysis

Track how Unjha Formulations technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish10
Bullish2
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
-0.1
Bullish
CCI (20)
43.23
Neutral
RSI (14)
0
Bullish
Momentum (10)
0
Neutral
ADI (14)
96.7
Neutral
Ultimate Oscillator (7,14,28)
0
Bearish

Moving Averages

Name

Value

Action

SMA (20)
19.57
Bearish
EMA (20)
19.59
Bearish
VWMA (20)
19.51
Bearish
SMA (50)
19.82
Bearish
EMA (50)
19.74
Bearish
SMA (200)
19.95
Bearish
EMA (200)
19.82
Bearish
KAMA (200)
19.5
Bearish
DEMA (200)
19.94
Bearish

Unjha Formulations Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Unjha Formulations with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Unjha Formulations Ltd image
Unjha Formulations Ltd
NA8.7414.21%0.00NA13
Sakar Healthcare Ltd image
Sakar Healthcare Ltd
BUY1,857.7675.21%0.6217177
Medicamen Biotech Ltd image
Medicamen Biotech Ltd
NA346.94-10.73%0.576162
Aarey Drugs & Pharmaceuticals Ltd image
Aarey Drugs & Pharmaceuticals Ltd
NA245.4319.94%0.004473
Morepen Laboratories Ltd image
Morepen Laboratories Ltd
NA3,330.46-3.12%0.571181,811
See all

Unjha Formulations Stock’s Investor Sentiment and Interest

Search interest for Unjha Formulations Ltd Stock has increased by 37% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:37% versus previous 30 day period

Unjha Formulations Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Sales
4.76
5.55
4.43
3.95
3.78
3.76
2.37
3.61
4.29
4.41
3.28
Other Income
0.01
-
0.01
-
0.02
0.01
-
0.02
0.06
-
-
Total Income
4.77
5.54
4.44
3.95
3.81
3.77
2.44
3.63
4.35
4.44
3.33
Expenses
4.87
5.13
4.37
3.23
3.89
3.52
2.7
3.21
3.5
4.16
3.78
Operating Profit
-0.11
0.42
0.06
0.72
-0.11
0.24
-0.33
0.4
0.79
0.25
-0.5
Operating Profit Margin %
-2.31%
7.57%
1.35%
18.23%
-2.91%
6.38%
-13.92%
11.08%
18.41%
5.67%
-15.24%
Profit Before Interest, Tax and Depreciation
-0.1
0.41
0.07
0.72
-0.09
0.25
-0.26
0.42
0.85
0.28
-0.45
Interest
-
-
0.05
-
-
-
-
-
-
-
-
Depreciation
0.02
0.02
0.02
0.02
0.02
0.02
0.03
0.03
0.03
0.04
0.04
Profit Before Tax
-0.12
0.39
0
0.7
-0.11
0.23
-0.29
0.39
0.82
0.24
-0.49
Tax Paid
-
-
0.18
-
-
-
0.12
-
-
-
0.25
Profit After Tax
-0.12
0.39
-0.18
0.7
-0.11
0.22
-0.41
0.39
0.82
0.24
-0.74
Total Net profit including share of profit / Loss from associate company
-0.12
0.39
-0.18
0.7
-0.11
0.22
-0.41
0.39
0.82
0.24
-0.74
EPS
0.14
0.87
-0.39
1.56
-0.25
0.5
-0.91
0.9
1.83
0.53
-1.66
Actual EPS
0.14
0.87
-0.39
1.56
-0.25
0.5
-0.91
0.9
1.83
0.53
-1.66
Adjusted EPS
0.14
0.87
-0.39
1.56
-0.25
0.5
-0.91
0.9
1.83
0.53
-1.66
Diluted EPS
0.14
0.87
-0.39
1.56
-0.25
0.5
-0.91
0.9
1.83
0.53
-1.66

Unjha Formulations Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
11.3
11.42
10.6
9.96
14.16
13.15
18.5
13.86
15.59
Other Income
-
-
0.26
0.22
0.19
0.03
0.01
-
-
Total Income
11.33
11.52
10.86
10.17
14.35
13.18
18.51
13.98
15.75
Expenses
10.95
11.12
10.35
9.81
13.84
12.72
17.92
13.35
14.65
Operating Profit
0.35
0.3
0.25
0.15
0.32
0.43
0.58
0.51
0.94
Operating Profit Margin %
3.1%
2.63%
2.36%
1.51%
2.26%
3.27%
3.14%
3.68%
6.03%
Profit Before Interest, Tax and Depreciation
0.38
0.41
0.5
0.36
0.51
0.46
0.59
0.63
1.1
Interest
0.02
0.02
0.12
0.17
0.13
0.06
0.06
0.01
0.01
Depreciation
0.1
0.09
0.08
0.08
0.08
0.08
0.08
0.1
0.14
Profit Before Tax
0.26
0.3
0.3
0.11
0.3
0.32
0.45
0.52
0.95
Tax Paid
-
-
-
-
0.05
0.05
0.18
0.12
0.25
Profit After Tax
0.26
0.3
0.31
0.1
0.25
0.28
0.28
0.41
0.7
Total Net profit including share of profit / Loss from associate company
0.26
0.3
0.31
0.1
0.25
0.28
0.28
0.41
0.7
EPS
0.58
0.67
0.69
0.23
0.56
0.63
0.62
0.91
1.57
Actual EPS
0.58
0.67
0.69
0.23
0.56
0.63
0.62
0.91
1.57
Adjusted EPS
0.58
0.67
0.69
0.23
0.56
0.63
0.62
0.91
1.57
Diluted EPS
0.58
0.67
0.69
0.23
0.56
0.63
0.62
0.91
1.57

Unjha Formulations Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
0.41
0.39
0.14
-0.12
0.39
-0.7
0.28
-0.26
1.03
-0.04
Cash Flow from Investing Activities
-0.02
-0.28
0.06
0.04
-0.1
-0.06
-0.02
-0.1
-0.11
-0.18
Cash Flow from Financing Activities
-0.4
0.05
-0.05
0.23
-
-
-
-0.06
-0.05
-0.01
Net Cash Flow
-0.01
0.15
0.15
0.16
0.29
-0.77
0.25
-0.42
0.86
-0.23

Unjha Formulations Stock Shareholding Pattern

Numbers in percentages

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
36.92%
36.92%
36.92%
36.92%
36.92%
36.92%
36.92%
36.92%
36.92%
36.92%
36.92%
Public
63.08%
63.08%
63.08%
63.08%
63.08%
63.08%
63.08%
63.08%
63.08%
63.08%
63.08%
Total Outstanding Shares
44,80,500
44,80,500
44,80,500
44,80,500
44,80,500
44,80,500
44,80,500
44,80,500
44,80,500
44,80,500
44,80,500
Total Shareholders
3,993
4,012
3,933
3,985
3,969
4,208
4,273
4,213
4,284
4,251
4,235

Unjha Formulations Corporate Actions

View detailed summary of the earnings and dividend history of Unjha Formulations.

  • Unjha Formulations Ltd Earnings Results

    Unjha Formulations Ltd’s net profit fell -80.49% since last year same period to ₹0.74Cr in the Q4 2025-2026. On a quarterly growth basis, Unjha Formulations Ltd has generated -408.33% fall in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Unjha Formulations Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 153.5% return, outperforming this stock by 91.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 43.9% return, outperforming this stock by 59.0%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 36.93% of holdings in Mar 2026 quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 63.08% of holdings in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, Unjha Formul. stock has moved down by -1.8%

About Unjha Formulations Ltd

Established in June 1987, Unjha Formulations is a manufacturer of pharmaceuticals based in the Mehsana district of Gujarat. It produces a range of human and veterinary products, recently launching 4 new products in 199798, such as Bericof Protobal, NT Formentin Tablets, Nalizole and Isabgol Husk based products. The company has experienced major success in expanding its customer base in India and has even made attempts to export their products to other countries, achieving an export turnover of Rs.0.98 during 199798, with a confirmed export order of Rs.30.00 lacs. Unjha Formulations is one of the largest suppliers of Isabgol in India.

Revenue: ₹3.28Cr as on March 2026 (Q4 FY26)
Net Profit: ₹0.74Cr as on March 2026 (Q4 FY26)
Chairperson Name: Jashodaben S Patel
OrganisationUnjha Formulations Ltd
HeadquartersPatan
IndustryPharmaceuticals
CEOJashodaben S Patel
E-voting on sharesClick here to vote

FAQs

What is Unjha Formulations share price today?

Unjha Formulations share price today stands at ₹19.5 as on . Unjha Formulations share today touched a day high of ₹19.99 and a low of ₹19.5.

What is the 52 week high and 52 week low range for Unjha Formulations share?

Unjha Formulations touched a 52 week high of ₹30.4 and a 52 week low of ₹17.52. Unjha Formulations share price today i.e. is trending at ₹19.5, which is -35.86% down from its 52 week high and 11.30% up from its 52 week low.

What is Unjha Formulations's market capitalisation today?

Unjha Formulations market capitalisation is ₹8.74 Cr as on .

How to buy Unjha Formulations shares?

To buy Unjha Formulations shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 531762 or Unjha Formulations Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Unjha Formulations shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Unjha Formulations trading volume today?

Unjha Formulations trading volume is 1,520.00 as on . This means that 1,520.00 shares of Unjha Formulations were bought and sold on the stock market during today's trading session.